Page 106 - AN-3-2
P. 106

Advanced Neurology                                          X chromosome-mediated risk in Alzheimer’s disease




            Table 6. Comparison of populations and methods between the present study and the previous study 17
            Attribute                           Present study (UPDB)        Previous study (Cognitive Disorders Clinic) 17
            Population                    Deceased individuals in a database  Patients presenting to the clinic, mostly for initial
                                                                            diagnosis
            Diagnosis                     Based on death certificates       Based on clinical criteria to diagnose early disease
            Percentage of probands in     3% (4436/149303)                  22% (71/320)
            population from which they were
            drawn
            Proband sex ratio (F: M)      64:36=2:1                         40:31=1.3:1
            Age-based inclusion criteria  No                                Between 55 and 80 years at presentation
            Proband age                   85 years (median) at death (range 39 – 103)  66.1±5.1 years for women and 68.1±6.5 years for
                                                                            men at presentation (mean±standard deviation)
            Unilateral parental family history   Methods do not permit the exclusion of   Methods specifically excluded 25 “bilateral” cases
                                          “bilateral” cases
            Observation                   Only 40 probands (<1%) had a parent with   In most probands, it was a parent who had
                                          AD identified (14 fathers, 27 mothers)  AD/dementia


            had AD as compared to the chances of identifying male   (several hundred) would be required to replicate, with
            patients whose mothers had AD or female patients whose   greater sensitivity, the results of our earlier study. 17
            fathers or mothers had AD. However, the low number
            of patients in the clinic study was the main reason this   4.3.2. Future genetic studies
            population-based database study was conducted, and it is   A more ambitious goal of future research would be to seek
            instructive to note that insofar as identifying large absolute   genetic localization of X chromosome changes. Following
            numbers of parents of patients with AD who also had AD,   the approach of relying on individuals with a unilateral
            we were not more successful with the population-based   family history of disease, a much larger number of incident
            database. Furthermore, this is not a unique circumstance.   cases are needed to compare the X chromosomes of men
            We conclude that searching for risk factors for AD, including   with a maternal family history of AD (that might carry
            genetic risk factors, has severe limitations when performed   some risks for the disease) to those of men with a paternal
            in prevalent populations or deceased populations.  history of the disease (which would not be carrying risk

            4.3. Implications for future research              factors for the disease). A  modified design would be
                                                               needed to perform a similar analysis in women with
            4.3.1. Future epidemiological studies              unilateral parental history of disease because 50% of their
            Pinpointing the role of an elusive risk factor, the X   X chromosomes might not confer risk for disease. If each
            chromosome, will require that special efforts be invested   X  chromosome  could  be  identified as  arising  from  the
            in the methodology of the search. We suggest that a   affected or the unaffected parent, it would be appropriate
            strategy based on looking for X-linked genetic risk in the   to compare the X chromosome from the affected female
            subpopulation of LOAD patients with a unilateral family   parent to that from the unaffected female parent. While
            history of the disease may increase the yield of the search.   the specifics of designing genetic studies are beyond the
            Epidemiological evidence for the contribution of the X   scope of this project, we suggest that looking for genetic
            chromosome to the development of AD will need to be   risk factors in the subset of patients with a unilateral family
            sought prospectively in incident patient populations with   history of LOAD may provide new insights into the sex-
            newly diagnosed aMCI or LOAD and a positive family   specific genetic causes of AD, which have been elusive thus
            history for an amnestic disorder. Contemporary studies   far. A possible direction may be to focus on genes already
            should avail themselves of confirmation of the diagnosis   known to be responsible for mental functions, which are
                                                      28
            of AD in the probands using biologic markers.  A   represented disproportionately on the X chromosome,
            standardized protocol will be needed to acquire a family   comprising perhaps 15% of the total genes responsible for
            history from these patients. While family history may be   mental functions,  while only 4% of the total number of
                                                                             29
            limited in many patients, it may be positive in close to   protein-coding genes in the genome are represented on
                                                                               30
            30%; of these – perhaps upto three-quarters may report   the X chromosome.  The X chromosome is represented
            unilateral parental lineage, or 22% (absolute). A relatively   disproportionately in the Online Mendelian Inheritance in
            small number of patients with unilateral parental lineage   Man (OMIM) listing of genes linked to mental retardation.


            Volume 3 Issue 2 (2024)                         7                                doi: 10.36922/an.3122
   101   102   103   104   105   106   107   108   109   110   111